Lipase, also known as glyceride hydrolase, is a type of enzyme with multiple catalytic abilities. It can catalyze the hydrolysis, alcoholysis, esterification, and transesterification of triglycerides and other water-insoluble esters, and promote the reverse conversion of esters. The synthesis reaction is an important part of the organism's process of promoting lipids to enter the metabolic cycle. Lipase in mammals mainly originates from the pancreas, followed by the stomach and small intestine, and can hydrolyze a variety of glycerides containing long-chain fatty acids with low specificity. Significant changes in its activity usually reflect damage to the pancreas and other related diseases.

The global Lipase (LPS) Activity Assay Kit market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Lipase (LPS) Activity Assay Kit Industry Forecast” looks at past sales and reviews total world Lipase (LPS) Activity Assay Kit sales in 2023, providing a comprehensive analysis by region and market sector of projected Lipase (LPS) Activity Assay Kit sales for 2024 through 2030. With Lipase (LPS) Activity Assay Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lipase (LPS) Activity Assay Kit industry.

This Insight Report provides a comprehensive analysis of the global Lipase (LPS) Activity Assay Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lipase (LPS) Activity Assay Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lipase (LPS) Activity Assay Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lipase (LPS) Activity Assay Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lipase (LPS) Activity Assay Kit.

United States market for Lipase (LPS) Activity Assay Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Lipase (LPS) Activity Assay Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Lipase (LPS) Activity Assay Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Lipase (LPS) Activity Assay Kit players cover Elabscience, Beijing Antu Biotechnology, Ningbo Yijie Biotechnology, Guangzhou Datai Biotechnology, Mindray Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Lipase (LPS) Activity Assay Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Methylresorufin Substrate Method
• Colorimetry
• Others

Segmentation by Application:

• Hospital
• Lab
• Others

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Elabscience
• Beijing Antu Biotechnology
• Ningbo Yijie Biotechnology
• Guangzhou Datai Biotechnology
• Mindray Medical
• Roche
• Sigma-Aldrich Co. LLC
• Randox
• Thermo Fisher
• BioVision Inc.
• Abcam plc
• Cayman Chemistry
• Cell Biolabs, Inc.
• Wako Pure Chemical Industries, Ltd.
• Crystal Chem, Inc.
• EKF Diagnostics Holdings plc
• BioAssay Systems
• EnzyChrom Bioassays
• Sekisui Medical Co., Ltd.
• Pointe Scientific, Inc.
• Diagnostic Automation/Cortez Diagnostics, Inc.

Key Questions Addressed in this Report

1. What is the 10-year outlook for the global Lipase (LPS) Activity Assay Kit market?
2. What factors are driving Lipase (LPS) Activity Assay Kit market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Lipase (LPS) Activity Assay Kit market opportunities vary by end market size?
5. How does Lipase (LPS) Activity Assay Kit break out by Type, by Application?